Goodwill and Intangible Assets

6 Months Ended

Jun. 30, 2011

Goodwill and Intangible Assets [Abstract]

5. Goodwill and Intangible Assets

	Goodwill activity during the six months ended June 30, 2011 was as follows:

			Payer		Provider		Pharmacy		Total
	Balance at December 31, 2010		$	322,101	$	502,227	$	83,982	$	908,310
	Acquisitions			18,418		-		-		18,418
	Changes in preliminary purchase price allocation			-		(564)		-		(564)
	Balance at June 30, 2011		$	340,519	$	501,663	$	83,982	$	926,164

	Intangible assets subject to amortization as of June 30, 2011 consist of the following:

					Gross
		Weighted Average			Carrying		Accumulated
		Remaining Life			Amount		Amortization		Net
	Customer relationships	14.4			$	1,062,113	$	(206,059)	$	856,054
	Trade names	14.3				121,678		(23,922)		97,756
	Non-compete agreements	3.8				19,656		(12,875)		6,781
	Data sublicense agreement	6.6				49,600		(10,056)		39,544
	Backlog	0.3				22,120		(15,061)		7,059
	Total				$	1,275,167	$	(267,973)	$	1,007,194

	Amortization expense was $46,301 and $33,153 for the six months ended June 30, 2011 and 2010, respectively.

	Aggregate future amortization expense for intangible assets is estimated to be:

	2011 (remainder)								$	43,741
	2012									74,462
	2013									73,789
	2014									73,516
	2015									71,896
	Thereafter									669,790
									$	1,007,194

- Definition

Discloses the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain or loss on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss. This element may be used as a single block of text to include the entire intangible asset disclosure including data and tables.

+ References+ Details